Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aarti Asnani

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of the American College of Cardiology|April 19, 2023
New Insights Into Cardiac Wasting in Patients With CancerAarti Asnani
Journal of the American College of Cardiology|May 19, 2018
Beta-Blockers for Primary Prevention of Anthracycline Cardiotoxicity: Not Quite Ready for Prime TimeAarti Asnani
Current Oncology Reports|April 13, 2018
Cardiotoxicity of Immunotherapy: Incidence, Diagnosis, and ManagementAarti Asnani
Circulation Research|September 30, 2021
Activating Autophagy to Prevent Doxorubicin Cardiomyopathy: The Timing MattersAarti Asnani
Current Problems in Cancer|September 4, 2018
Cardiotoxicities associated with immune checkpoint inhibitorsShu Yang, Aarti Asnani
Current Cardiology Reports|May 27, 2018
Biomarker Discovery in Cardio-OncologyAnita Vohra, Aarti Asnani
Cardiovascular Research|February 7, 2019
Cardioprotection in cancer therapy: novel insights with anthracyclinesInbar Raber, Aarti Asnani
Disease Models & Mechanisms|June 29, 2014
The zebrafish as a tool to identify novel therapies for human cardiovascular diseaseAarti Asnani, Randall T Peterson
JACC. Cardiooncology|February 19, 2025
Frailty: Can a Biological Aging Marker Enhance Precision Risk Assessment of Cancer Therapy Cardiotoxicity?Mina S Sedrak, Aarti Asnani
JACC. Cardiooncology|February 18, 2026
Functional Genomics Illuminates Mechanisms of Anthracycline CardiotoxicityAnthony M Pettinato, Aarti Asnani
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of the American College of Cardiology|April 19, 2023
New Insights Into Cardiac Wasting in Patients With CancerAarti Asnani
Journal of the American College of Cardiology|May 19, 2018
Beta-Blockers for Primary Prevention of Anthracycline Cardiotoxicity: Not Quite Ready for Prime TimeAarti Asnani
Current Oncology Reports|April 13, 2018
Cardiotoxicity of Immunotherapy: Incidence, Diagnosis, and ManagementAarti Asnani
Circulation Research|September 30, 2021
Activating Autophagy to Prevent Doxorubicin Cardiomyopathy: The Timing MattersAarti Asnani
Current Problems in Cancer|September 4, 2018
Cardiotoxicities associated with immune checkpoint inhibitorsShu Yang, Aarti Asnani
Current Cardiology Reports|May 27, 2018
Biomarker Discovery in Cardio-OncologyAnita Vohra, Aarti Asnani
Cardiovascular Research|February 7, 2019
Cardioprotection in cancer therapy: novel insights with anthracyclinesInbar Raber, Aarti Asnani
Disease Models & Mechanisms|June 29, 2014
The zebrafish as a tool to identify novel therapies for human cardiovascular diseaseAarti Asnani, Randall T Peterson
JACC. Cardiooncology|February 19, 2025
Frailty: Can a Biological Aging Marker Enhance Precision Risk Assessment of Cancer Therapy Cardiotoxicity?Mina S Sedrak, Aarti Asnani
JACC. Cardiooncology|February 18, 2026
Functional Genomics Illuminates Mechanisms of Anthracycline CardiotoxicityAnthony M Pettinato, Aarti Asnani
Pageof 9